|
Characteristics
|
IPC N. (%)
|
VCT N. (%)
|
Total N. (%)
|
|---|
|
All participants
|
108 (6.2%)
|
1,644 (93.8%)
|
1,752 (100%)
|
|
WHO clinical stage at initial clinic visit*
| | | |
|
1 or 2
|
75 (7.8%)
|
880 (92.2%)
|
955 (100.0%)
|
|
3 or 4
|
15 (4.2%)
|
344 (95.8%)
|
359 (100.0%)
|
|
CD4 count at initial clinic visit**
| | | |
|
>350 cells/mm3
|
45 (10.4%)
|
386 (89.6%)
|
431 (100.0%)
|
|
≤350 cells/mm3
|
27 (6.3%)
|
403 (93.7%)
|
430 (100.0%)
|
|
Mean CD4 count at initial clinic visit (cells/μl)
|
368.0
|
298.1
|
304.0
|
|
95% CI (cells/μl)
|
(305.0 – 431.0)
|
(280.1 – 316.2)
|
(286.6 – 321.4)
|
|
Age
| | | |
|
50 years and under
|
80 (5.4%)
|
1,405 (94.6%)
|
1,485 (100.0%)
|
|
Over 50 years
|
28 (10.5%)
|
239 (89.5%)
|
267 (100.0%)
|
|
Gender
| | | |
|
Female
|
73 (6.5%)
|
1,046 (93.5%)
|
1,119 (100.0%)
|
|
Male
|
35 (5.5%)
|
598 (94.5%)
|
633 (100.0%)
|
|
Marital status***
| | | |
|
Married
|
73 (8.1%)
|
830 (91.9%)
|
903 (100.0%)
|
|
Never married
|
4 (2.1%)
|
184 (97.9%)
|
188 (100.0%)
|
|
Divorced/widowed
|
23 (4.7%)
|
464 (95.3%)
|
487 (100.0%)
|
- *438, **891, ***174 missing values.
